Sickle cell disease: caring for people with leg ulcers in heal-thcare services
DOI:
https://doi.org/10.12957/reuerj.2024.79186Keywords:
Nursing Care, Enterostomal Therapy, Leg Ulcer, Anemia, Sickle Cell, Health Care LevelsAbstract
Objective: to identify the location and direct care received by people with leg ulcers due to sickle cell disease in health care services. Method: a cross-sectional study carried out in 11 centers from August 2019 to April 2020. The study included 72 people with active leg ulcers. The study was approved by the Research Ethics Committee. Results: a total of 91.7% of the participants had sickle cell anemia, with a median of three years of ulcer existence; 77.8% were recurrent; 40.3% bought the supplies; 66.7% changed their own dressings at home; 52.8% did one or more changes a day; 45.8% of the treatments were prescribed by physician; 37.5% were ointments (collagenase or antibiotics); and 89% did not use compression to manage edema. Conclusion: most of the participants were not included in the Health Care Network for ulcer treatment and did not receive systematized care or appropriate supplies.
References
Pecker LH, Lanzkron S. Sickle cell disease. Ann Inter Med. 2021 [cited 2024 Apr 15]; 174(1):ITC1-16. DOI: https://doi.org/10.7326/AITC202101190.
AlDallal SM. Mini review: leg ulcers - a secondary complication of sickle cell disease. Int J Gen Med. 2019 [cited 2024 Apr 15]; 12:279-82. DOI: https://doi.org/10.2147/IJGM.S217369.
Dick A, Schwartzman G, Khachemoune A. Cutaneous manifestations of sickle cell disease: an updated review. Arch Dermatol Res. 2023 [cited 2024 Apr 15]; 315(4):729-34. DOI: https://doi.org/10.1007/s00403-022-02466-5.
Minniti CP, Knight-Madden J, Tonda M, Gray S, Lehrer-Graiwer J, Biemond BJ. The impact of voxelotor treatment on leg ulcers in patients with sickle cell disease. Am J Hematol. 2021 [cited 2024 Apr 15]; 96(4):E126-8. DOI: https://doi.org/10.1002/ajh.26101.
Antwi-Boasiako C, Andemariam B, Colombatti R, Asare EV, Strunk C, Piccone CM, et al. A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis. Ann Hematol. 2020 [cited 2024 Apr 15]; 99(9):2073-9. DOI: https://doi.org/10.1007/s00277-020-04057-8.
Kaliyadan F, Alkhars AZ, Albaqshi AA, AlHajri HM, Albaqshi NK, Aldihnayn RM, et al. Prevalence and predictive factors for leg ulcers in sickle cell disease patients in Saudi Arabia: a cross-sectional observational study. Cureus. 2020 [cited 2024 Apr 15]; 12(10):e11280. DOI: https://doi.org/10.7759%2Fcureus.11280.
Spira JA, Borges EL, Guedes AC, Andrade PG, Lima VL. Prevalence of people with sickle cell disease and leg ulcers in Brazil: Socioeconomic and clinical overview. PLoS ONE. 2022 [cited 2024 Apr 15]; 17(9):e0274254. DOI: https://doi.org/10.1371/journal.pone.0274254.
Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008 [cited 2024 Apr 15]; 61(4):344-9. DOI https://doi.org/10.1016/j.jclinepi.2007.11.008.
Ministério da Saúde (Br). Instituto Nacional de Câncer (Inca). Cuidados paliativos oncológicos: controle da dor. Rio de Janeiro: Inca; 2001 [cited 2024 Apr 15]. Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//cuidados-paliativos-oncologicos-2002.pdf.
Koshy M, Entsuah R, Koranda A, Kraus AP, Johnson R, Bellvue R, et al. Leg ulcers in patients with sickle cell disease. Blood. 1989 [cited 2024 Apr 15]; 74(4):1403-8. Available from: https://www.sciencedirect.com/science/article/pii/S0006497120825944.
Belisário AR, Mendes-Oliveira F, de Souza VR, Bolina-Santos E, Mendes FG, Moreno EC, et al. Association between inflammatory molecules, nitric oxide metabolites and leg ulcers in individuals with sickle cell anemia. Hematol Transfus Cell Ther. 2022 [cited 2024 Apr 15]; 44(2):169-76. DOI: https://doi.org/10.1016%2Fj.htct.2020.09.152.
Umeh NI, Ajegba B, Buscetta AJ, Abdallah KE, Minniti CP, Bonham VL. The psychosocial impact of leg ulcers in patients with sickle cell disease: I don't want them to know my little secret. PLoS One. 2017 [cited 2024 Apr 15]; 12(10):e0186270. DOI: https://doi.org/10.1371/journal.pone.0186270.
Ministério da Saúde (Br). Secretaria de Atenção à Saúde. Departamento de Atenção Hospitalar e de Urgência. Doença falciforme: diretrizes básicas da linha de cuidado. Brasília, DF: 2015 [cited 2024 Apr 15]. Available from: https://bvsms.saude.gov.br/bvs/publicacoes/doenca_falciforme_diretrizes_basicas_linha_cuidado.pdf.
Mburu J, Odame I. Sickle cell disease: Reducing the global disease burden. Int J Lab Hematol. 2019 [cited 2024 Apr 15]; 41(Suppl 1):82-88. DOI: https://doi.org/10.1111/ijlh.13023.
Ministério da Saúde (Br). Comissão nacional de Incorporação de Tecnologias no SUS. Protocolo clínico e diretrizes terapêuticas doença falciforme. Brasília, DF: Ministério da Saúde; 2018 [cited 2024 Apr 15]. Available from: http://antigo-conitec.saude.gov.br/images/Relatorios/2018/Relatorio_PCDT_Doenca_Falciforme.pdf.
Ministério da Saúde (Br). Secretaria de Atenção à Saúde. Departamento de Atenção Especializada. Manual de anemia falciforme para agentes comunitários de saúde. Brasília, DF: Ministério da Saúde; 2006 [cited 2024 Apr 15]. Série A. Normas e Manuais Técnicos. Available from: https://www.nupad.medicina.ufmg.br/wp-content/uploads/2016/12/Manual-de-Anemia-Falciforme-para-ACSs.pdf.
Gomes LM, Pereira IA, Torres HC, Caldeira AP, Viana MB. Access and care of individuals with sickle cell anemia in a primary care service. Acta Paul Enferm. 2014 [cited 2024 Apr 15]; 27(4):348-55. DOI: https://doi.org/10.1590/1982-0194201400058.
Onimoe G, Rotz S. Sickle cell disease: a primary care update. Cleve Clin J Med. 2020 [cited 2024 Apr 15]; 87(1):19-27. DOI: https://doi.org/10.3949/ccjm.87a.18051.
Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Especializada. Doença falciforme: úlceras: prevenção e tratamento. Brasília, DF: Ministério da Saúde; 2012 [cited 2024 Apr 15]. Série B. Textos Básicos de Saúde. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/doenca_falciforme_ulceras_prevencao_tratamento.pdf.
Mainous AG 3rd, Rooks B, Tanner RJ, Carek PJ, Black V, Coates TD. Shared care for adults with sickle cell disease: an analysis of care from eight health systems. J Clin Med. 2019 [cited 2024 Apr 15]; 8(8):1154. DOI: https://doi.org/10.3390/jcm8081154.
Araujo MA, Ferreira BE, Meira MS, Mucuta NJ, Andrade RR, Oliveira TH, et al. Conhecimento e prática de enfermagem no atendimento à doença falciforme e hemoglobinopatias na Atenção Primária. Texto Contexto - Enferm. 2023 [cited 2024 Apr 15]; 32:e20220276. DOI: https://doi.org/10.1590/1980-265X-TCE-2022-0276pt.
Minniti CP, Kato GJ. Critical Reviews: How we treat sickle cell patients with leg ulcers. Am J Hematol. 2016 [cited 2024 Apr 15]; 91(1):22-30. DOI: https://doi.org/10.1002/ajh.24134.
Geethakumari K, Kusuma YS, Babu BV. Beyond the screening: The need for health systems intervention for prevention and management of sickle cell disease among tribal population of India. Int J Health Plann Manage. 2021 [cited 2024 Apr 15]; 36(2):236-43. DOI: https://doi.org/10.1002/hpm.3081.
Ribeiro DF. Care management to chronic wound carriers in Primary Health Care. Rev Enferm Atual in Derme. 2019 [cited 2024 Apr 15]; 90(28). DOI: https://doi.org/10.31011/reaid-2019-v.90-n.28-art.503.
Oliveira AM, Rocha PS. Diagnóstico situacional do tratamento de feridas na atenção primária no município de Belém-PA. Rev Enferm Atual in Derme. 2022 [cited 2024 Apr 15]; 96(38):e-021252. DOI: https://doi.org/10.31011/reaid-2022-v.96-n.38-art.1327.
Spira JA, Borges EL, Pires Júnior JF, Monteiro DS, Kitagawa KY. Estimated costs in treating sickle cell disease leg ulcer. Rev Esc Enferm USP. 2020 [cited 2024 Apr 15]; 54:e03582. DOI: https://doi.org/10.1590/S1980-220X2018053603582.
Monfort JB, Senet P. Leg ulcers in sickle-cell disease: treatment update. Adv Wound Care (New Rochelle). 2020 [cited 2024 Apr 15];9(6):348-56. DOI: https://doi.org/10.1089/wound.2018.0918.
Tiscar-González V, Menor-Rodríguez MJ, Rabadán-Sainz C, Fraile-Bravo M, Styche T, Valenzuela-Ocaña FJ, et al. Clinical and economic impact of wound care using a polyurethane foam multilayer dressing. Adv Skin Wound Care. 2021 [cited 2024 Apr 15]; 34(1):23-30. DOI: https://doi.org/10.1097/01.ASW.0000722744.20511.71.
Weller CD, Team V, Sussman G. First-line interactive wound dressing update: a comprehensive review of the evidence. Front Pharmacol. 2020 [cited 2024 Apr 15]; 11:155. DOI: https://doi.org/10.3389/fphar.2020.00155.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Josimare Aparecida Otoni Spira, Eline Lima Borges, Paula Gabriela Ribeiro Andrade, Cristiane Rabelo Lisboa, Maria Leticia Menezes Souza
This work is licensed under a Creative Commons Attribution 4.0 International License.
When publishing in Revista Enfermagem UERJ, the authors declare that the work is their exclusive authorship and therefore assume full responsibility for its content.
Authors retain copyright to their article and agree to license their work using a Creative Commons Attribution International Public License (CC BY), thereby accepting the terms and conditions of this license (https://creativecommons.org/licenses/by/4.0/legalcode.en), which allows material created by the author to be distributed, copied and displayed by third parties. The original work must be cited and present a link to the article available on the website of the journal in which it was published.
The Copyright of the articles published in Revista Enfermagem UERJ belongs to their respective author(s), with the rights of first publication assigned to Revista Enfermagem UERJ, with the work simultaneously licensed under a Creative Commons License CC BY, which allows sharing of work with recognition of authorship and initial publication in this journal.
The authors grant Revista Enfermagem UERJ the right of first publication, to identify themselves as the original publisher of the work and grant the magazine a license of non-exclusive rights to use the work in the following ways:
- Sell and/or distribute the work in printed copies and/or electronic format;
- Distribute parts and/or the work as a whole with the aim of promoting the magazine through the internet and other digital and printed media;
- Record and playback work in any format, including digital media.
In line with the journal's policies, each published article will be assigned a Creative Commons Attribution (CC BY) license.
